Immunic Inc (NASDAQ:IMUX)’s traded shares stood at 0.48 million during the last session, with the company’s beta value hitting 1.78. At the close of trading, the stock’s price was $1.38, to imply an increase of 2.99% or $0.04 in intraday trading. The IMUX share’s 52-week high remains $2.82, putting it -104.35% down since that peak but still an impressive 31.16% since price per share fell to its 52-week low of $0.95. The company has a valuation of $124.31M, with an average of 259.16K shares over the past 3 months.
Immunic Inc (NASDAQ:IMUX) trade information
After registering a 2.99% upside in the last session, Immunic Inc (IMUX) has traded red over the past five days. The stock hit a weekly high of 1.4292, jumping 2.99% in its intraday price action. The 5-day price performance for the stock is 27.78%, and 8.66% over 30 days. With these gigs, the year-to-date price performance is -8.00%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Immunic Inc (IMUX) estimates and forecasts
Looking at statistics comparing Immunic Inc share performance against respective industry, we note that the company has outperformed competitors. Immunic Inc (IMUX) shares are 11.29% up over the last 6 months, with its year-to-date growth rate higher than industry average at 52.61% against 15.40%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 31.12% for the past 5-year period. While 2024 is set for a 52.61% return in earnings, projections for the next 5 years are at 15.50% annually.
IMUX Dividends
Immunic Inc has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Immunic Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Immunic Inc (NASDAQ:IMUX)’s Major holders
Immunic Inc insiders hold 7.72% of total outstanding shares, with institutional holders owning 64.28% of the shares at 69.66% float percentage. In total, 64.28% institutions holds shares in the company, led by BVF Inc. . As of Mar 31, 2024 , the company held over 8.9 shares (or 9.88% of shares), all amounting to roughly $12.29 million.
The next major institution holding the largest number of shares is Avidity Partners Management, LP with 8.9 shares, or about 9.88% of shares outstanding. As of the market price on Mar 31, 2024 , these shares were worth $12.29 million.
